109 related articles for article (PubMed ID: 8695166)
21. Estramustine binding protein in human brain-tumor tissue.
von Schoultz E; Bergenheim T; Grankvist K; Henriksson R
J Neurosurg; 1991 Jun; 74(6):962-4. PubMed ID: 1709687
[TBL] [Abstract][Full Text] [Related]
22. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
Prewett M; Rothman M; Waksal H; Feldman M; Bander NH; Hicklin DJ
Clin Cancer Res; 1998 Dec; 4(12):2957-66. PubMed ID: 9865906
[TBL] [Abstract][Full Text] [Related]
23. The expression of estramustine-binding protein in the human prostatic cancer cell line DU 145 is not androgen dependent.
Eklöv S; Larson A; Björk P; Nilsson S
Scand J Urol Nephrol; 1992; 26(2):119-25. PubMed ID: 1626200
[TBL] [Abstract][Full Text] [Related]
24. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
26. Distribution of estramustine-binding protein during postnatal development of rat brain.
Karlsson AE; Bergenheim AT; Brännström T; Hedman H; Henriksson R
Histochem Cell Biol; 2001 May; 115(5):397-401. PubMed ID: 11449887
[TBL] [Abstract][Full Text] [Related]
27. Estramustine binding protein in primary tumours and metastases of malignant melanoma.
von Schoultz E; Carlström K; Henriksson R; Lagerlöf B; Hansson J
Melanoma Res; 1994 Dec; 4(6):401-5. PubMed ID: 7703721
[TBL] [Abstract][Full Text] [Related]
28. Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.
Oosterwijk E; Bander NH; Divgi CR; Welt S; Wakka JC; Finn RD; Carswell EA; Larson SM; Warnaar SO; Fleuren GJ
J Clin Oncol; 1993 Apr; 11(4):738-50. PubMed ID: 8478666
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression of estramustine binding protein (EMBP) in prostatic intraepithelial neoplasia (PIN) compared with malignant and benign prostatic epithelia.
de la Torre M; Eklöv S; Häggman M; Björk P; Busch C; Nilsson S
Prostate; 1994 Sep; 25(3):125-31. PubMed ID: 7520576
[TBL] [Abstract][Full Text] [Related]
30. Study of estramustine binding protein (EMBP): purification of rat EMBP and establishment of RIA.
Shiina H; Ishibe T; Usui T
Biochem Biophys Res Commun; 1989 Dec; 165(3):947-55. PubMed ID: 2482024
[TBL] [Abstract][Full Text] [Related]
31. Estramustine binding protein in human benign prostatic hypertrophy.
Shiina H; Mizutani M; Ishibe T
Andrologia; 1990; 22(4):309-12. PubMed ID: 1702270
[TBL] [Abstract][Full Text] [Related]
32. Expression of estramustine-binding protein in ependymomas and in human and developing rat ependymal cells.
Bergenheim AT; Hartman M; Bergh J; Ridderheim PA; Henriksson R
J Neurooncol; 1994; 22(1):45-53. PubMed ID: 7714550
[TBL] [Abstract][Full Text] [Related]
33. Expression of an estramustine-binding associated protein in human lung cancer cell lines.
Bergh J; Björk P; Westlin JE; Nilsson S
Cancer Res; 1988 Aug; 48(16):4615-9. PubMed ID: 2840198
[TBL] [Abstract][Full Text] [Related]
34. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.
Lawrentschuk N; Lee FT; Jones G; Rigopoulos A; Mountain A; O'Keefe G; Papenfuss AT; Bolton DM; Davis ID; Scott AM
Urol Oncol; 2011; 29(4):411-20. PubMed ID: 19523858
[TBL] [Abstract][Full Text] [Related]
35. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
36. Expression of estramustine-binding protein (EMBP) and the proliferation-associated antigen Ki-67 in prostatic carcinomas.
Nilsson S; Nordgren H; Karlberg L; Harvig B; Busch C; Hall T; Björk P
Scand J Urol Nephrol Suppl; 1988; 110():31-7. PubMed ID: 3187428
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma.
Jungwirth A; Schally AV; Pinski J; Groot K; Armatis P; Halmos G
Proc Natl Acad Sci U S A; 1997 May; 94(11):5810-3. PubMed ID: 9159156
[TBL] [Abstract][Full Text] [Related]
38. Targeting microtubule-associated proteins in glioblastoma: a new strategy for selective therapy.
Piepmeier JM; Pedersen PE; Yoshida D; Greer C
Ann Surg Oncol; 1996 Nov; 3(6):543-9. PubMed ID: 8915486
[TBL] [Abstract][Full Text] [Related]
39. Estramustine-binding protein--a marker for effect of therapy in prostatic carcinoma?
Björk PA; Flüchter SH; Nelde HJ
Scand J Urol Nephrol Suppl; 1988; 107():59-64. PubMed ID: 3287599
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.
Mizutani Y; Nakanishi H; Yoshida O; Fukushima M; Bonavida B; Miki T
Eur J Cancer; 2002 Jan; 38(1):167-76. PubMed ID: 11750847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
